ORLANDO, Viviana
 Distribuzione geografica
Continente #
NA - Nord America 612
EU - Europa 452
AS - Asia 148
AF - Africa 15
SA - Sud America 2
Totale 1.229
Nazione #
US - Stati Uniti d'America 605
IT - Italia 331
SG - Singapore 51
IN - India 41
SE - Svezia 38
CN - Cina 29
FI - Finlandia 22
DE - Germania 14
TG - Togo 13
BG - Bulgaria 10
GB - Regno Unito 9
UA - Ucraina 9
FR - Francia 8
CA - Canada 7
ID - Indonesia 7
IR - Iran 5
TR - Turchia 5
BE - Belgio 4
RO - Romania 3
KZ - Kazakistan 2
PK - Pakistan 2
PT - Portogallo 2
AR - Argentina 1
BD - Bangladesh 1
BH - Bahrain 1
BR - Brasile 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JP - Giappone 1
KG - Kirghizistan 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 1.229
Città #
Rome 206
Fairfield 104
Ashburn 66
Woodbridge 40
Seattle 38
Singapore 32
Cambridge 30
Wilmington 29
Chandler 28
Ann Arbor 27
Houston 25
Princeton 19
Beijing 15
Lomé 13
Fasano 12
Plano 12
Millbury 11
Helsinki 10
San Paolo di Civitate 10
Sofia 10
Dearborn 8
Lawrence 8
New York 8
Washington 8
Jakarta 7
San Diego 7
Boston 6
Andover 5
Fremont 5
Boardman 4
Brussels 4
Florence 4
Istanbul 4
Norwalk 4
Salerno 4
Avellino 3
Des Moines 3
Hefei 3
Jacksonville 3
Oxford 3
Philadelphia 3
Phoenix 3
Pontelandolfo 3
Pune 3
Redwood City 3
Rogliano 3
Southend 3
Aprilia 2
Bari 2
Cassano delle Murge 2
Crévic 2
Dijon 2
Falkenstein 2
Kunming 2
Lappeenranta 2
Naples 2
Ottawa 2
Padula 2
Tappahannock 2
Tianjin 2
Toronto 2
Waltham 2
Abidjan 1
Absecon 1
Alatri 1
Albuquerque 1
Almaty 1
Anaheim 1
Ankara 1
Berlin 1
Bishkek 1
Bologna 1
Budapest 1
Busto Arsizio 1
Ceccano 1
Changchun 1
Chicago 1
Cinisello Balsamo 1
Dallas 1
Dublin 1
Fairview 1
Falls Church 1
Federal 1
Ferndale 1
Galdo 1
Gloucester 1
Holon 1
Liscate 1
London 1
Los Angeles 1
Milan 1
Muizenberg 1
Mumbai 1
Nanjing 1
Napoli 1
New Delhi 1
Oakville 1
Oristano 1
Palermo 1
Parma 1
Totale 927
Nome #
Drug design and synthesis of first in class PDZ1 targeting NHERF1 inhibitors as anticancer agents 166
Anticancer activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a new dishevelled 1 inhibitor 118
Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies 97
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 87
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: Implication in peripheral inflammation 81
Discovery of pyrrole derivatives for the treatment of glioblastoma and chronic myeloid leukemia 79
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles 65
Toward an objective evaluation of cell transfection performance 63
Modulating intracellular acidification by regulating the incubation time of proton caged compounds 61
Exogenous control over intracellular acidification: Enhancement via proton caged compounds coupled to gold nanoparticles and an alternative pathway with DMSO 59
Transfection of mouse neuroblastoma N18TG2 cells with Metafectene Pro reagent 58
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 56
Direct HPLC enantioseparation of chiral aptazepine derivatives on coated and bonded polysaccharide-based chiral stationery phases. 52
Acetylcholine induces changes in protein folding regimen and cytoskeleton organization 49
Surface functionalized multicomponent envelope type nanosystems for improved gene delivery 49
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 48
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 48
null 32
Top-down n-doped carbon quantum dots for multiple purposes: Heavy metal detection and intracellular fluorescence 26
Inflammatory cytokines and cholinergic system dis-function in multiple sclerosis patients. 8
Totale 1.302
Categoria #
all - tutte 3.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 20 41 32 26 26 37 8 10
2020/2021102 13 8 7 6 1 4 4 10 10 11 14 14
2021/2022248 14 3 26 10 20 8 9 18 35 17 36 52
2022/2023191 40 42 8 9 17 13 5 12 31 7 6 1
2023/2024214 18 22 14 10 14 29 18 23 12 16 25 13
2024/202580 20 14 21 21 4 0 0 0 0 0 0 0
Totale 1.302